Text Presentation
Acute cerebral venous sinus thrombosis (CVST) is not an infrequent medical emergency in the Indian population. Out of 30% of young strokes it accounts for 10-20% of all strokes in India 1 . It is a disease with potentially serious consequences. It is seen that 53% of patients with stupor/coma on admission have died with standard Heparin therapy 2 . Large number of cases of venous strokes is seen in Indian practice daily. They are still treated on case-to-case basis depending on the experience of treating Physician. Local catheter based thrombolytic therapy is an emerging powerful technique in the management of venous strokes. Thrombolytic treatment has been reported to be safe and effective in the management of cases of cerebral venous sinus thrombosis who have poor prognosis.
Large number of cases are diagnosed and treated by our institute. A subgroup of them comes to our notice. Most of the patients seen by us had bad prognostic features like raised intracranial pressure, coma, intractable seizures and focal neurological deficits etc. An attempt was made to understand the disease by the sheer volume of cases presenting to our institution for last 10 years. After lot of consideration we developed a protocol for the management of patients with venous strokes. Our experience shows that managing patients according to our protocol has clearly improved outcome in this disease.
Here we share our experience with the disease in our institute.
We studied the disease in three Phases.. In Phase I all patients were treated with systemic heparin. In Phase II few patients were taken up for local thrombolysis. These patients were deteriorating on systemic heparinization. With encouraging results in Phase II we designed protocol and in Phase III selection of cases for local thrombolysis was according to a defined protocol( KEM INR Protocol).
The protocol was formulated considering the clinical presentation, imaging and angiographic findings. ii) hemoptysis, hematuria, G I Bleed. After Thrombolysis all patients were subjected to systemic anticoagulation with heparin followed by oral anticoagulation for 6 months.
KEM INR Criteria for Local thrombolysis for
Technique: If the diagnosis of cerebral venous sinus thrombosis was suggested clinically and supported on CT scan and Thrombolysis contemplated patients were subjected to digital subtraction angiography. On cerebral angiograms thrombosis of dural sinus and cortical veins with restriction to venous outflow were confirmed. The transit time was invariably prolonged (>12 sec). The cortical veins appeared to' hang in space' in delayed venous phases (figures 1-7).
A dedicated cerebral angiography with late venous phases is performed in all patients. Once patients fulfill all the inclusion criteria, thrombolysis is done. A transfemoral venous access is secured with a 6F femoral sheath. 6F-guiding catheter is placed in the right or left Jugular bulb. Then Mechanical clot maceration is done with a '38' Glide wire (Terumo corp.Japan),after which a microcatheter over a microwire is navigated into the thrombosed segment of the dural sinus. A check venogram confirms the position of catheter tip in thrombosed sinus and then Urokinase infusion is started at the rate of 60,000-100,000 units/hr. The infusion is continued till there is brisk flow in the sinuses, which is confirmed with check venogram at every 10 hrs. The average dose of urokinase required in our patients is 2.4 million units. However some patients required urokinase infusion up to 4 days. Once the sinuses are thrombolysed, which is con-
firmed with, antegrade flow and complete wash out of the contrast on venogram, thrombolysis is stopped and check four vessel angiogram is performed in all cases. Once thrombolysis is stopped patients are treated with systemic anticoagulation followed by oral anticoagulation for 6 months.
Large number of studies on venous strokes is available from Indian subcontinent and most of cases reported are postpartum. However the cases coming to us showed a male predominance an all three phases. The disease appeared to be more severe in males. In Phase I all patients were treated with conventional he- parin therapy irrespective of the grades they were in. These patients were only referred for cerebral angiography to us. On follow up we found that the outcome was grim in these patients. There was 100% mortality seen in patients with severe clinical grade.
In Phase II we treated 26 cases with local thrombolysis. These patients were referred to us when they not responding to standard treatment with heparin or were deteriorating on it. These were anecdotal cases. We had no defined criteria for treating them. Our results with thrombolysis were good with no complications of urokinase therapy. The mortality in thrombolysed group was 57.14% compared to nonthrombolysed group, which had mortality of 75%. With encouraging results in Phase II we designed a protocol to manage patients with cerebral venous sinus thrombosis.
In Phase III we managed all patients according to our protocol. Patients fulfilling the inclusion criteria were taken up for thrombolysis. Our patients were graded according to the protocol and were treated as said. The results are promising and the mortality in severe clinical grade has come down to 35% in Phase III from 100% in Phase I and 75%in Phase II. It is noticed that patients treated with standard heparin therapy in severe clinical grade in Phase 3 also had 100% mortality. Our experience clearly shows that local thrombolytic therapy is highly effective in the management of cerebral venous sinus thrombosis especially in patients with severe clinical grade.
Discussion
Cerebral venous sinus thrombosis is a common clinical condition and has widespread clinical presentation from mild headaches to deep coma. Despite the universal treatment strategy with systemic heparinization and associated symptomatic treatment the mortality still continues to be in the range of 10-13.8% in recent studies 3, 4 .
These cases of 'malignant venous strokes'
(patients in severe clinical grade with rapidly progressive disease with large hemorrhagic infarcts and restriction to venous outflow) despite adequate heparinisation and management of raised ICT, seizures and metabolic derangements have a fatal outcome. This group needs more aggressive intervention to decrease morbidity and mortality. Patients with bad prognostic factors, such as extremes of age, coma, severely raised ICT, uncontrollable seizures, involvement of deep venous system, and hemorrhagic infarcts on CT scan have been found to have bad prognosis despite optimum medical management. These patients who do not have enough collaterals and have restrictive venous outflow are more likely to die. Clinical and angiographic criteria can identify this group of patients and they can be treated more aggressively.
This technique can be carried out in all centers in where the expertise and infrastructure is available. Most of recent small series outside India report use of local rtPA because of its affinity for fibrin 5 . We have no experience with it.
Local thrombolytic therapy is an effective technique for sinus recanalisation providing outflow to brain venous return. This was seen clearly seen in our experience. Previous studies indicate mortality of 53% in bad prognostic group 2 which can be a significantly decreased with local Urokinase thrombolysis.
Designing a protocol helps us grade the seriousness of disease in individual patient. It helps us identify group of cases at higher risk that can benefit from thrombolysis.
Managing patients according to the protocol has helped us in better outcome of patients with significant decrease in mortality and morbidity. For last 6 years it is an accepted treatment paradigm for patients of venous strokes in our institute.
We believe that this PROTOCOL will also be useful to the clinicians elsewhere who treat patients with Dural venous sinus thrombosis and a venous stroke.
